SUIVAC APP

SUIVAC APP

emulsion for injection for pigs

The liquid vaccine containing inactivated bacterium Actinobacillus pleuropneumoniae to ensure an active immunization of pigs against porcine pleuropneumonia. The active ingredient of the of the product represent toxoids APX I, II and III, outer membrane proteins and lipopolysaccharides of inactivated bacterium Actinobacillus pleuropneumoniae of serotypes 2 and 9.

Each one dose contains

Active substances:

Actinobacillus pleuropneumoniae inactivatum serotype 2 and 9 ≥ 1 U*.

U*: antibodies amount interpreted by a number of units U in reference serum according to Ph. Eur. monograph.

Each 1 ml contains

Adjuvants:

oil emulsion NLT 0.15 ml,

saponin NMT 0.05 mg.

Excipients:

thiomersal NMT 0.10 mg,

formaldehyde NMT 0.50 mg,

solvent into 1.0 ml 

 

Indications

An active prophylactic immunization of pigs against porcine actinobacillosis of pigs. The vaccine is designed for immunization of pigs at an age from 6 weeks, pigs at the end of fattening and pregnant animals to ensure protection of their piglets by specific colostral immunity against porcine actinobacillosis of pigs. The immunity develops within 2 to 3 weeks after primary vaccination. Full immunity is achieved approximately over 2 weeks after re-vaccination of animals. In young animals, the immunity persists up to the end of fattening at least. If immunization is made at the end of fattening, the immunity will increase again. In sows the immunity persists until further re-vaccination at gestation.

 

Contraindication 

Do not use in animals with developed clinical signs of the disease, piglets up to 6 weeks of age and pregnant animals 2 weeks prior to expected farrowing and during lactation.

 

Dosage and method of administration

For i.m. administration

The immunization dose per 1 animal is 2 ml, irrespective of age, sex and weight. The vaccine should be administered deep intramuscularly (i.m.) at the site of the neck, behind the ear.

For i.d. administration

The immunization dose per 1 animal is 0.2 ml, irrespective of age, sex and weight. The vaccine should be administered intradermally (i.d.) using an applicator without a needle into the skin. When this type of applicator is used for a dose of 0.1 ml, the vaccination dose should be administered twice, sized 0.1 ml each, side by side. Intradermal administration should be made behind ear caudally, in young pigs also at the dorsal area of the back. 

Pigs should be vaccinated from an age of 6 weeks and re-vaccinated over 3 to 4 weeks. In case of an impaired infectious situation, pigs can be immunized at the end of fattening via a third dose. The immunization should be made only by i.d. route in order to inhibit potential granulomatous alterations at the site of administration on i.m. immunization.

Pregnant gilts and sows should be subject to primary vaccination approximately 8 to 6 weeks prior to expected farrowing with re vaccination over 3 to 4 weeks. The sows are maintained in immunity by regular revaccination 4 to 2 weeks prior to every next expected farrowing.

 

Size of package

For i.m. administration: 1 x 5 doses, 1 x 25 doses,1 x 50 doses, 1 x 250 doses,  

For i.d. administration: 1 x 25 doses, 1 x 50 doses, 1 x 250 doses, 1 x 500 doses

Not all pack sizes may be marketed.

 

For animals only. Veterinary medicinal product to be supplied only on veterinary prescription.